Thymic protein A can be effective at fighting the symptoms of Chronic Fatigue and Immune Dysfunction Syndrome (CFIDS), according to a recent study. CFIDS is characterised by unexplained, persistent fatigue that interferes with the ability to carry out normal daily activities.
The study, conducted by a team led by Michael Rosenbaum and published in the December 2001 issue of the Journal of Nutritional and Environmental Medicine, was designed to determine if the oral administration of thymic protein A would produce noticeable results in patients suffering from CFIDS.
The study was funded by Longevity Science and Genicel, makers of the patented thymic protein A supplement ProBoost.
Sixteen of the 23 patients in Rosenbaum's study showed marked improvement in immune system function, with a corresponding improvement of the clinical symptoms of CFIDS.
"This study suggests that the restoration of proper immune regulation with thymic protein A can ameliorate symptoms associated with CFIDS," said Rosenbaum. Data obtained from the study showed improvement in various blood markers used to diagnose CFIDS, including specific T-cell counts and increased white blood cell counts.
Many patients also reported dramatic improvements in the symptoms associated with CFIDS, including a 47 per cent improvement in sleep quality, a 43 per cent reduction of food sensitivities, a 53 per cent reduction of chemical sensitivities, a 47 per cent improvement in short term memory, a 79 per cent improvement in depression, and a 100 per cent improvement in panic reactions.
There were also similar improvements in sore throat frequency, swollen lymph glands, nasal allergies, muscle weakness, anxiety, and canker sores.
"ProBoost contains the identical thymic protein that is depleted in humans due to the inevitable shrinkage of the thymus gland which begins at puberty. The loss of thymic function results in a lowering of immune readiness and reduced ability to handle infectious agents when they attack the body. Thymic protein A acts as a potent immune regulator, by activating the key T-4 helper white blood cells and restoring immune function. We believe that this restoration of proper immunity caused the significant improvement in CFIDS symptoms of a majority of the participants in this study," said Longevity Science in a statement.